PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)Roy M. Gulick, Kenneth H. Mayer, Craig W. Hendrix et al.|The Journal of Infectious Diseases|2016Cited by 47
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in WomenRoy M. Gulick, Kenneth H. Mayer, Timothy Wilkin et al.|Annals of Internal Medicine|2017Cited by 31
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Ian McGowan, Marybeth McCauley, Ian Frank et al.|eScholarship (California Digital Library)|2020Cited by 28
Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed InfantsCarolyne Onyango‐Makumbi, Mary Glenn Fowler, Arthur H. Owora et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2019Cited by 7